logo BDSP

Base documentaire

  1. The direct economic costs of insomnia in the United States for 1995.

    Article - En anglais

    Study Objectives 

    To assess the direct economic costs of insomnia in the United States in 1995.


    The costs of prescription medications were based on 1995 data compiled by IMS America, Ltd. (Plymouth Meeting, PA).

    Non-prescription medication expenditures were provided by Information Resources, Inc. (Chicago, IL).

    The costs of physician visits related to insomnia were estimated from unpublished data of the 1994 National Ambulatory Medical Care Survey conducted by the National Center for Health Statistics and from the America Medical Association Center for Health Policy Research.

    Several other sources were used for other cost estimates.


    Total cost for substances used to treat insomnia was $1.97 billion, less than half of which was for prescription medication.

    Health care services for insomnia totaled $11.96 billion, 91% of which is attributable to nursing home care.

    The total direct costs in the United States for insomnia in 1995 were estimated to be $13.9 billion. (...)

    Mots-clés Pascal : Insomnie, Etats Unis, Amérique du Nord, Amérique, Service santé, Economie santé, Sédatif, Hypnotique, Tranquillisant, Trouble sommeil, Psychotrope, Homme

    Mots-clés Pascal anglais : Insomnia, United States, North America, America, Health service, Health economy, Sedative, Hypnotic, Tranquillizer, Sleep disorder, Psychotropic, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0359968

    Code Inist : 002B18C14. Création : 14/12/1999.